Keybank National Association Cocrystal Pharma, Inc. Transaction History

Keybank National Association

  • $25.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 30, 2019
SELL
$1.6 - $3.68 $77,540 - $178,343
-48,463 Closed
0 $0
Q3 2018

Nov 08, 2018
SELL
$2.3 - $4.95 $67,955 - $146,252
-29,546 Reduced 37.88%
48,463 $121,000
Q2 2018

Aug 08, 2018
BUY
$1.79 - $6.25 $139,636 - $487,556
78,009 New
78,009 $286,000

About Cocrystal Pharma, Inc.

COCP Quotes by TradingView
  • Ticker COCP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,122,420
  • Market Cap $14.3M
  • Description
  • Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...
More about COCP
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email